
1. Moving the Markets
Stocks ended at par today as Wall Street reacted to a resumed slide in oil prices and braced for the Federal Reserve’s decision Wednesday on interest rates.
A major driver of the recent stock market rally has been a sharp rebound in oil prices. But U.S.-produced crude has reversed course the past two trading sessions and has resumed its fall amid fresh worries about oversupply, which has weighed on market sentiment. A barrel of West Texas Intermediate crude closed down 2.3%, to $36.45.
Investors were also digesting the decision of the Bank of Japan not to slash interest rates further, after surprising markets back in January when it cut rates into negative territory for the first time. The BOJ left rates unchanged and didn’t boost its stimulus measures currently in place.
In pharmaceutical news today, we heard that shares of Valeant Pharmaceuticals International (VRX) suffered their worst one-day plunge ever, losing more than half their value after the embattled drug maker issued lower earnings and financial forecasts and outlined potential bond defaults that could affect the firm’s borrowing. Ouch!


Central banks around the world, especially the European Central Bank (ECB), have done a pretty good job of preventing the downside, but they really have not kicked up the upside with respect to economic growth, said John Silvia, chief economist at Wells Fargo Securities.
Actively managed exchange-traded funds have failed to capture investors’ imagination in the US despite the overall ETF industry growing apace with assets under management crossing $2 trillion in 2015. Actively managed fixed income funds, however, have fared better by cornering two-thirds of the $24 billion overall active niche.